With nearly 70% of clinical decisions now being made on the basis of laboratory diagnostic testing, the power of today’s molecular lab has never been stronger.1 To further strengthen this position, microbiology labs can look to consolidation as a means to streamline processes, improve productivity and reduce costs to keep pace with changing healthcare economics.
The consolidation of microbiology lab testing services is a cost-saving strategy that eliminates duplication and improves testing efficiencies.2 Research suggests that the consolidation of lab services can produce significant cost savings without compromising efficiency or quality of service.3
At Roche, efficiency, patient care, and lab staff satisfaction drive the future. Consolidation ushers in an era of change, and Roche is embracing and driving it. The future make-up of molecular labs will mirror that of clinical chemistry labs, reflecting an automated, streamlined, and efficient architecture, where quality, speed, and reliability are of the essence.